Literature DB >> 32086708

Cancer Therapy and Imaging Through Functionalized Carbon Nanotubes Decorated with Magnetite and Gold Nanoparticles as a Multimodal Tool.

Fatemeh Saghatchi1, Masoud Mohseni-Dargah2, Shiva Akbari-Birgani3,4, Samaneh Saghatchi5, Babak Kaboudin1,6.   

Abstract

Pharmacotherapy and imaging are two critical facets of cancer therapy. Carbon nanotubes and their modified species such as magnetic or gold nanoparticle conjugated ones they have been introduced as good candidates for both purposes. Gold nanoparticles enhance effects of X-rays during radiotherapy. Nanomaterial-mediated radiofrequency (RF) hyperthermia refers to using RF to heat tumors treated with nanomaterials for cancer therapy. The combination of hyperthermia and radiotherapy, synergistically, causes a significant reduction in X-ray doses. The present study was conducted to investigate the ability and efficiency of the multi-walled carbon nanotubes functionalized with magnetic Fe3O4 and gold nanoparticles (mf-MWCNT/AuNPs) for imaging and cancer therapy. The mf-MWCNT/AuNPs were utilized for imaging approaches such as ultrasounds, CT scan, and MRI. They were also examined in thermotherapy and radiotherapy. The MCF-7 cell line was used as an in vitro model to study thermotherapy and radiotherapy. The mf-MWCNT/AuNPs are beneficial as a contrast agent in imaging by ultrasounds, CT scan, and MRI. They are also radio waves and X-rays absorbent and enhance the efficiency of thermotherapy and radiotherapy in the elimination of cancer cells. The valuable properties of mf-MWCNT/AuNPs in radio- and thermotherapies and imaging strategies make them a good candidate as a multimodal tool in cancer therapy. Graphical Abstract The mf-MWCNT/AuNPs are beneficial as a contrast agent in imaging by US (ultrasounds), CT scan, and MRI. They are also radio waves and X-rays absorbent and enhance the efficiency of thermotherapy and radiotherapy in the elimination of cancer cells. The valuable properties of the mf-MWCNT/AuNPs in radio- and thermotherapies and imaging strategies make them a good candidate as a multimodal tool in cancer therapy.

Entities:  

Keywords:  Cancer therapy; Gold nanoparticle; Imaging; Multi-walled carbon nanotube; Radiotherapy; Thermotherapy

Mesh:

Substances:

Year:  2020        PMID: 32086708     DOI: 10.1007/s12010-020-03280-3

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  6 in total

Review 1.  Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics.

Authors:  Ayushi Rai; Saba Noor; Syed Ishraque Ahmad; Mohamed F Alajmi; Afzal Hussain; Hashim Abbas; Gulam Mustafa Hasan
Journal:  Medicina (Kaunas)       Date:  2021-01-21       Impact factor: 2.430

Review 2.  Insights on functionalized carbon nanotubes for cancer theranostics.

Authors:  Lu Tang; Qiaqia Xiao; Yijun Mei; Shun He; Ziyao Zhang; Ruotong Wang; Wei Wang
Journal:  J Nanobiotechnology       Date:  2021-12-16       Impact factor: 10.435

Review 3.  Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.

Authors:  Lu Tang; Jing Li; Ting Pan; Yue Yin; Yijun Mei; Qiaqia Xiao; Ruotong Wang; Ziwei Yan; Wei Wang
Journal:  Theranostics       Date:  2022-02-21       Impact factor: 11.556

4.  Fractal Dimension-Based Infection Detection in Chest X-ray Images.

Authors:  Sujata Ghatak; Satyajit Chakraborti; Mousumi Gupta; Soumi Dutta; Soumen Kumar Pati; Abhishek Bhattacharya
Journal:  Appl Biochem Biotechnol       Date:  2022-09-21       Impact factor: 3.094

Review 5.  Remotely Activated Nanoparticles for Anticancer Therapy.

Authors:  Luisa Racca; Valentina Cauda
Journal:  Nanomicro Lett       Date:  2020-10-27

6.  Plasmonic photothermal release of docetaxel by gold nanoparticles incorporated onto halloysite nanotubes with conjugated 2D8-E3 antibodies for selective cancer therapy.

Authors:  Reza Taheri-Ledari; Wenjie Zhang; Maral Radmanesh; Nicole Cathcart; Ali Maleki; Vladimir Kitaev
Journal:  J Nanobiotechnology       Date:  2021-08-11       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.